在药物标签中对药物基因组信息的评估:来自约旦的案例研究
Yazun Jarrar1, Nancy Hakooz2, Mays Abu Ajamieh2
1Department of Basic Medical Sciences, Faculty of Medicine, Al-Balqa Applied University, Al-Salt, Jordan.
Personalized medicine
|July 15, 2025
概括
在约旦,药物基因组学 (PGx) 标签是有限的,只有20%的JFDA批准的药物含有基本遗传信息. 这凸显了对更新法规的迫切需要,以推动该地区的个性化医疗.
科学领域:
- 药物基因组学 药物基因组学
- 临床药理学 临床药理学
- 药物开发 药物开发
背景情况:
- 药物基因组学 (PGx) 研究影响药物反应的遗传变异,以实现个性化医疗.
- 药物标签是将PGx信息传达给临床医生的关键道.
- 在许多国家 (包括约旦) 观察到PGx在临床实践中的有限整合.
研究的目的:
- 评估约旦食品和药物管理局 (JFDA) 批准的药物中药物基因组学 (PGx) 标签的可用性.
- 将约旦的PGx标签实践与美国和匈牙利的标签实践进行比较.
主要方法:
- 从JFDA在线数据库中对药物说明书的手动审查 (2024年7月至9月).
- 根据PGx信息的存在或不存在来对药物进行分类.
- 与美国FDA的PGx生物标记表和匈牙利SmPCs进行比较分析.
主要成果:
- 在75种由JFDA批准的药物中,只有15种 (20%) 含有完整的PGx信息.
- 神经学,精神病学和瘤学显示了更高的PGx标签率,而心脏病学和泌尿病学则代表性不足.
- 与美国和匈牙利相比,约旦的PGx标签的普遍性明显较低.
结论:
- 在约旦,在药物基因组学 (PGx) 标签上存在很大的差距.
- 监管更新对于促进个性化医疗的采用至关重要.
- 在药物标签上增强PGx信息对于改善患者护理至关重要.
相关概念视频
Pharmacovigilance
996
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
996
Drug Regulation
1.9K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.9K
Factors Affecting Drug Response: Overview
2.4K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.4K
Factors Affecting Protein-Drug Binding: Patient-Related Factors
116
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
116
Analysis of Population Pharmacokinetic Data
390
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
390
Factors Influencing Drug Absorption: Disease States and Pharmacology
809
Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
809


